Tofacitinib 2% Gel in Childhood Vitiligo: Report of a Case of Significant Improvement.

The article presents a case study of an 11-year-old boy with vitiligo who experienced significant improvement with topical tofacitinib gel, highlighting its potential as a promising treatment modality for vitiligo in pediatric patients. Topics discussed include the mechanism of action of tofacitinib in vitiligo treatment, the favorable response observed in younger patients with darker skin types, and the possibility of monotherapy with topical tofacitinib without the need for phototherapy.